A growth in the number of its functional support partnerships in areas such as biostatistics and statistical programming has prompted Quanticate to relocate to North Carolina’s Research Triangle.
The global clinical research organisation (CRO) will move its US office from Boston to Research Triangle, already home to a number of biotech and life science companies.
Daniel Chapple, Quanticate’s chief commercial officer, said: “Due to a number of large-scale partnerships being awarded to Quanticate, we saw the need to expand our US presence and relocate our US headquarters to the Research Triangle in North Carolina.
“This move provides us with the opportunity of operating within a scalable and growing business region dedicated to the life science industry.”
The move is part of a larger global initiative at the CRO that is aimed at continuing growth in its programming, statistics, medical writing, data management and pharmacovigilance operations.
Jointly headquarters in the UK and the US, Quanticate will open its new North Carolina office in the third quarter of this year.